Literature DB >> 19001877

KDM2A represses transcription of centromeric satellite repeats and maintains the heterochromatic state.

David Frescas1, Daniele Guardavaccaro, Shafi M Kuchay, Hiroyuki Kato, Andrey Poleshko, Venkatesha Basrur, Kojo S Elenitoba-Johnson, Richard A Katz, Michele Pagano.   

Abstract

Heterochromatin plays an essential role in the preservation of epigenetic information, the transcriptional repression of repetitive DNA elements and inactive genes, and the proper segregation of chromosomes during mitosis. Here we identify KDM2A, a JmjC-domain containing histone demethylase, as a heterochromatin-associated and HP1-interacting protein that promotes HP1 localization to chromatin. We show that KDM2A is required to maintain the heterochromatic state, as determined using a candidate-based approach coupled to an in vivo epigenetic reporter system. Remarkably, a parallel and independent siRNA screen also detected a role for KDM2A in epigenetic silencing. Moreover, we demonstrate that KDM2A associates with centromeres and represses transcription of small non-coding RNAs that are encoded by the clusters of satellite repeats at the centromere. Dissecting the relationship between heterochromatin and centromeric RNA transcription is the basis of ongoing studies. We demonstrate that forced expression of these satellite RNA transcripts compromise the heterochromatic state and HP1 localization to chromatin. Finally, we show that KDM2A is required to sustain centromeric integrity and genomic stability, particularly during mitosis. Since the disruption of epigenetic control mechanisms contributes to cellular transformation, these results, together with the low levels of KDM2A found in prostate carcinomas, suggest a role for KDM2A in cancer development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001877      PMCID: PMC2636745          DOI: 10.4161/cc.7.22.7062

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  43 in total

1.  Establishment and maintenance of a heterochromatin domain.

Authors:  Ira M Hall; Gurumurthy D Shankaranarayana; Ken-Ichi Noma; Nabieh Ayoub; Amikam Cohen; Shiv I S Grewal
Journal:  Science       Date:  2002-09-05       Impact factor: 47.728

2.  Integrative molecular concept modeling of prostate cancer progression.

Authors:  Scott A Tomlins; Rohit Mehra; Daniel R Rhodes; Xuhong Cao; Lei Wang; Saravana M Dhanasekaran; Shanker Kalyana-Sundaram; John T Wei; Mark A Rubin; Kenneth J Pienta; Rajal B Shah; Arul M Chinnaiyan
Journal:  Nat Genet       Date:  2006-12-17       Impact factor: 38.330

3.  High-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms.

Authors:  Richard A Katz; Emily Jack-Scott; Anna Narezkina; Ivan Palagin; Pamela Boimel; Joseph Kulkosky; Emmanuelle Nicolas; James G Greger; Anna Marie Skalka
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

4.  Cell cycle control of centromeric repeat transcription and heterochromatin assembly.

Authors:  Ee Sin Chen; Ke Zhang; Estelle Nicolas; Hugh P Cam; Martin Zofall; Shiv I S Grewal
Journal:  Nature       Date:  2008-01-23       Impact factor: 49.962

5.  Histone demethylation by a family of JmjC domain-containing proteins.

Authors:  Yu-ichi Tsukada; Jia Fang; Hediye Erdjument-Bromage; Maria E Warren; Christoph H Borchers; Paul Tempst; Yi Zhang
Journal:  Nature       Date:  2005-12-18       Impact factor: 49.962

6.  Cloning of a mammalian transcriptional activator that binds unmethylated CpG motifs and shares a CXXC domain with DNA methyltransferase, human trithorax, and methyl-CpG binding domain protein 1.

Authors:  K S Voo; D L Carlone; B M Jacobsen; A Flodin; D G Skalnik
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin.

Authors:  Bernhard Lehnertz; Yoshihide Ueda; Alwin A H A Derijck; Ulrich Braunschweig; Laura Perez-Burgos; Stefan Kubicek; Taiping Chen; En Li; Thomas Jenuwein; Antoine H F M Peters
Journal:  Curr Biol       Date:  2003-07-15       Impact factor: 10.834

8.  Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

Authors:  Jacques Lapointe; Chunde Li; John P Higgins; Matt van de Rijn; Eric Bair; Kelli Montgomery; Michelle Ferrari; Lars Egevad; Walter Rayford; Ulf Bergerheim; Peter Ekman; Angelo M DeMarzo; Robert Tibshirani; David Botstein; Patrick O Brown; James D Brooks; Jonathan R Pollack
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-07       Impact factor: 11.205

9.  Interaction of Epe1 with the heterochromatin assembly pathway in Schizosaccharomyces pombe.

Authors:  Sara Isaac; Julian Walfridsson; Tal Zohar; David Lazar; Tamar Kahan; Karl Ekwall; Amikam Cohen
Journal:  Genetics       Date:  2007-04       Impact factor: 4.562

10.  Human Orc2 localizes to centrosomes, centromeres and heterochromatin during chromosome inheritance.

Authors:  Supriya G Prasanth; Kannanganattu V Prasanth; Khalid Siddiqui; David L Spector; Bruce Stillman
Journal:  EMBO J       Date:  2004-06-24       Impact factor: 11.598

View more
  53 in total

Review 1.  Pericentric and centromeric transcription: a perfect balance required.

Authors:  Laura E Hall; Sarah E Mitchell; Rachel J O'Neill
Journal:  Chromosome Res       Date:  2012-07       Impact factor: 5.239

Review 2.  Transcription of tandemly repetitive DNA: functional roles.

Authors:  Maria Assunta Biscotti; Adriana Canapa; Mariko Forconi; Ettore Olmo; Marco Barucca
Journal:  Chromosome Res       Date:  2015-09       Impact factor: 5.239

3.  DNMT3B interacts with constitutive centromere protein CENP-C to modulate DNA methylation and the histone code at centromeric regions.

Authors:  Suhasni Gopalakrishnan; Beth A Sullivan; Stefania Trazzi; Giuliano Della Valle; Keith D Robertson
Journal:  Hum Mol Genet       Date:  2009-05-29       Impact factor: 6.150

4.  KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.

Authors:  Klaus W Wagner; Hunain Alam; Shilpa S Dhar; Uma Giri; Na Li; Yongkun Wei; Dipak Giri; Tina Cascone; Jae-Hwan Kim; Yuanqing Ye; Asha S Multani; Chia-Hsin Chan; Baruch Erez; Babita Saigal; Jimyung Chung; Hui-Kuan Lin; Xifeng Wu; Mien-Chie Hung; John V Heymach; Min Gyu Lee
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

5.  Identification of a functional network of human epigenetic silencing factors.

Authors:  Andrey Poleshko; Margret B Einarson; Natalia Shalginskikh; Rugang Zhang; Peter D Adams; Anna Marie Skalka; Richard A Katz
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

6.  Targeting Histone Demethylases: A New Avenue for the Fight against Cancer.

Authors:  Dante Rotili; Antonello Mai
Journal:  Genes Cancer       Date:  2011-06

7.  Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome.

Authors:  Arun K Nalla; Theodore F Williams; Casey P Collins; Dustin T Rae; Grant D Trobridge
Journal:  Mol Carcinog       Date:  2015-10-29       Impact factor: 4.784

Review 8.  Satellite non-coding RNAs: the emerging players in cells, cellular pathways and cancer.

Authors:  Daniela Ferreira; Susana Meles; Ana Escudeiro; Ana Mendes-da-Silva; Filomena Adega; Raquel Chaves
Journal:  Chromosome Res       Date:  2015-09       Impact factor: 5.239

9.  ATM-mediated KDM2A phosphorylation is required for the DNA damage repair.

Authors:  L-L Cao; F Wei; Y Du; B Song; D Wang; C Shen; X Lu; Z Cao; Q Yang; Y Gao; L Wang; Y Zhao; H Wang; Y Yang; W-G Zhu
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

10.  A demethylation deficient isoform of the lysine demethylase KDM2A interacts with pericentromeric heterochromatin in an HP1a-dependent manner.

Authors:  Dijana Lađinović; Jitka Novotná; Soňa Jakšová; Ivan Raška; Tomáš Vacík
Journal:  Nucleus       Date:  2017-08-17       Impact factor: 4.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.